We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current 0RFI market cap is 206.02M. The company's latest EPS is EUR -0.5093 and P/E is -18.52.
| Year End 30 September 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Total Revenue | 39.35M | 40.26M | 51.27M | 56.63M | 55.91M |
| Operating Income | -10.56M | -8.24M | -8.19M | -6.91M | -9.24M |
| Net Income | -9.68M | -4.97M | -6.59M | -8.28M | -11.13M |
| Year End 30 September 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Total Assets | 72.15M | 77.74M | 77.99M | 70.94M | 88.74M |
| Total Liabilities | 46.01M | 35.91M | 43.74M | 47.92M | 74.85M |
| Total Equity | 26.14M | 41.83M | 34.25M | 23.01M | 13.89M |
| Year End 30 September 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Operating | -4.77M | -3.91M | -1.49M | -4.22M | -3.58M |
| Investing | -4.47M | -2.18M | -12.69M | 562k | -1.69M |
| Financing | 13.09M | 11.57M | -1.97M | 459k | 26.99M |
| Market Cap | 206.02M |
| Price to Earnings Ratio | -18.52 |
| Price to Sales Ratio | 3.68 |
| Price to Cash Ratio | 7.58 |
| Price to Book Ratio | 14.84 |
| Dividend Yield | - |
| Shares Outstanding | 21.85M |
| Average Volume (1 week) | 39 |
| Average Volume (1 Month) | 39 |
| 52 Week Change | 0.00% |
| 52 Week High | 9.43 |
| 52 Week Low | 9.43 |
| Spread (Intraday) | 0.94 (9.49%) |
| Company Name | Brain Biotechnology Research And In |
| Address |
darmstaedter strasse 34-36 zwingenberg 64673 |
| Website | https://www.brain-biotech.de |
| Industry | biological pds,ex diagnstics (2836) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
